First Report of Successful CD38-Antagonist Daratumumab Augmented Carfilzomib-Based Treatment of Refractory Definite AMR of the Lung Allograft Meeting Abstract

cited authors

  • Kildea, M. N.; Ensor, C. R.; Kim, J.; Bogar, L.; Colella, D.; Davis, R. D.; Marschner, M.; Zeevi, A.; Soe, N.; Gries, C.

authors

Publication Date

  • April 1, 2020

webpage

published in

category

start page

  • 1145

end page

  • 1146

volume

  • 20